BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 8807220)

  • 1. Corticosteroid contact hypersensitivity: what vehicle and concentration?
    Wilkinson SM; Beck MH
    Contact Dermatitis; 1996 May; 34(5):305-8. PubMed ID: 8807220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patch testing to detect corticosteroid allergy: is it adequate?
    Seukeran DC; Wilkinson SM; Beck MH
    Contact Dermatitis; 1997 Mar; 36(3):127-30. PubMed ID: 9145260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patch testing for corticosteroid allergy with low and high concentrations of tixocortol pivalate and budesonide.
    Chowdhury MM; Statham BN; Sansom JE; Foulds IS; English JS; Podmore P; Bourke J; Orton D; Ormerod AD
    Contact Dermatitis; 2002 May; 46(5):311-2. PubMed ID: 12084094
    [No Abstract]   [Full Text] [Related]  

  • 4. Patch testing with corticosteroid mixes in Europe. A multicentre study of the EECDRG.
    Isaksson M; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Camarasa JG; Diepgen T; Ducombs G; Frosch PJ; Goossens A; Lahti A; Menné T; Rycroft RJ; Seidenari S; Shaw S; Tosti A; Wahlberg J; White IR; Wilkinson JD
    Contact Dermatitis; 2000 Jan; 42(1):27-35. PubMed ID: 10644022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for corticosteroid contact sensitivity. Comparison of tixocortol pivalate, hydrocortisone-17-butyrate and hydrocortisone.
    Lauerma AI
    Contact Dermatitis; 1991 Feb; 24(2):123-30. PubMed ID: 1828209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroid-induced contact dermatitis: a pragmatic approach.
    English JS
    Clin Exp Dermatol; 2000 Jun; 25(4):261-4. PubMed ID: 10971480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythema-multiforme-like contact dermatitis from budesonide.
    Stingeni L; Caraffini S; Assalve D; Lapomarda V; Lisi P
    Contact Dermatitis; 1996 Feb; 34(2):154-5. PubMed ID: 8681557
    [No Abstract]   [Full Text] [Related]  

  • 8. Contact hypersensitivity to corticosteroids in routine patch test patients. A multi-centre study of the Swiss Contact Dermatitis Research Group.
    Bircher AJ; Thürlimann W; Hunziker T; Pasche-Koo F; Hunziker N; Perrenoud D; Elsner P; Schultheiss R
    Dermatology; 1995; 191(2):109-14. PubMed ID: 8520055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of tixocortol pivalate-positive patch tests and questionable bioequivalence of different hydrocortisone preparations.
    Shaw DW; Maibach HI
    Contact Dermatitis; 2013 Jun; 68(6):369-75. PubMed ID: 23692037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contact hypersensitivity to tixocortol pivalate.
    Lutz ME; el-Azhary RA; Gibson LE; Fransway AF
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):691-5. PubMed ID: 9591812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of corticosteroid patch test preparations.
    Isaksson M; Gruvberger B; Persson L; Bruze M
    Contact Dermatitis; 2000 Mar; 42(3):144-8. PubMed ID: 10727164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact hypersensitivity to topical corticosteroids.
    Burden AD; Beck MH
    Br J Dermatol; 1992 Nov; 127(5):497-500. PubMed ID: 1467289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization studies with mometasone furoate, tixocortol pivalate, and budesonide in the guinea pig.
    Bruze M; Bjorkner B; Dooms-Goossens A
    Contact Dermatitis; 1996 Mar; 34(3):161-4. PubMed ID: 8833457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyvalent contact allergy to corticosteroids: a report of two cases.
    Semrádová V; Dastychová E
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):350-3. PubMed ID: 11730051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound allergy to topical budesonide.
    Corazza M; Mantovani L; Romani I; Bettoli V; Virgili A
    Contact Dermatitis; 1994 Apr; 30(4):246-7. PubMed ID: 8033558
    [No Abstract]   [Full Text] [Related]  

  • 16. Allergic reactions to topical corticosteroids or their vehicles.
    Fisher AA
    Cutis; 1983 Aug; 32(2):122, 129-32, 137. PubMed ID: 6225625
    [No Abstract]   [Full Text] [Related]  

  • 17. Corticosteroid contact hypersensitivity screening in Singapore.
    Khoo BP; Leow YH; Ng SK; Goh CL
    Am J Contact Dermat; 1998 Jun; 9(2):87-91. PubMed ID: 9601908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patch test results with tixocortol pivalate and budesonide in Germany and Austria.
    Uter W; Geier J; Richter G; Schnuch A;
    Contact Dermatitis; 2001 May; 44(5):313-4. PubMed ID: 11380156
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of contact hypersensitivity to topical corticosteroids with hydrocortisone-17-butyrate.
    Reitamo S; Lauerma AI; Förström L
    Contact Dermatitis; 1989 Sep; 21(3):159-65. PubMed ID: 2529100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patch-testing with serial dilutions of tixocortol pivalate and potential cross-reactive substances.
    Isaksson M; Bruze M; Goossens A; Lepoittevin JP
    Acta Derm Venereol; 2000; 80(1):33-8. PubMed ID: 10721831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.